Event-free Survival at 24 Months as a Surrogate Endpoint for DLBCL
Patients with diffuse large B-cell lymphoma (DLBCL) who achieved post-treatment event-free survival for 24 months had only a minimally lower life expectancy.
All articles by Waseem Qureshi
Vitamin D and Cancer: An Unclear Relationship
According to the National Cancer Institute, there are not enough available data to establish whether taking vitamin D can prevent cancer.
Kidney Cancer: Statin Use May Improve Disease-specific Survival
Statin use in patients with kidney cancer improved cancer-specific survival and overall survival.
Rotating Treatments in Renal Cell Carcinoma
ROPETAR failed to demonstrate any clinical benefit in alternating treatment with pazopanib and everolimus.
Treating Older Patients With Breast Cancer: Still a Challenge
Lack of research data and failure to consider patients’ functional age affects how older adults with breast cancer are managed.
Age Correlates With Incidence of RCC Among Pediatric Patients With Renal Malignancy
Researchers found that age and tumor size were the most significant factors for predicting renal cell carcinoma (RCC).
The US Health Care System Should Prepare and Participate in Changing Payment Models
Single bundle payments may be as effective for treatment, and much less expensive, than fee-for-service programs in health care.
Despite USPSTF Recommendation, PSA Screening Sticking Around
Prostate-specific antigen screening is not meaningfully less frequent than before guidelines were issued against use of the test.
Emerging Prognostic Markers Continue to Improve Myeloma Treatment
Newly-discovered and future biomarkers are likely to help oncologists give an accurate prognosis and to prescribe more effective treatment for patients with multiple myeloma.
Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC
Immunotherapy may be effective for some patients with NSCLC as a second-line treatment, but it’s unclear the role it will have in the first-line.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...